サマリー

市場の分析と洞察。レボフロキサシンの世界市場
COVID-19の大流行により、レボフロキサシンの世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年にレボフロキサシン世界市場の％を占めた250mgは、2028年までに百万米ドルの価値を持ち、COVID-19後の期間に改訂された％のCAGRで成長すると予測されています。一方、肺炎のセグメントは、この予測期間を通して％CAGRに変更されています。

中国のレボフロキサシン市場規模は2021年に百万米ドル、米国と欧州のレボフロキサシンはそれぞれ百万米ドル、百万米ドルとされています。2021年の米国の比率は％、中国と欧州はそれぞれ％と％で、中国の比率は2028年に％に達すると予測され、分析期間を通じてCAGRは％であることがわかりました。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパのLevofloxacinの状況については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。
レボフロキサシンの世界の主要メーカーは、Alna Biotech Private、Allenge India Pharma、Bestochem、Divine Savior Healthcare、Glenmark Pharmaceuticals、Pax Healthcare、Aden Healthcare、Lupin PharmaceuticalsおよびDr. Reddys Laboratoriesなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

世界のレボフロキサシンの範囲とセグメント
レボフロキサシン市場は、タイプ別と用途別に分類されます。世界のレボフロキサシン市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
250mg
500mg
750mg
用途別セグメント
肺炎
皮膚感染症
腎臓感染症
膀胱感染症
その他

会社別
アルナバイオテック社
アレンジャー インディア ファーマ
ベストケム
ディバインセイバーヘルスケア
グレンマーク・ファーマシューティカルズ
パックスヘルスケア
アデンヘルスケア
ルパン製薬
ドクター・レディス・ラボラトリーズ
ザイダス・カディラ

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Levofloxacin Product Introduction
1.2 Market by Type
1.2.1 Global Levofloxacin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 250 mg
1.2.3 500 mg
1.2.4 750 mg
1.3 Market by Application
1.3.1 Global Levofloxacin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pneumonia
1.3.3 Skin Infection
1.3.4 Kidney Infection
1.3.5 Bladder Infection
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Levofloxacin Sales Estimates and Forecasts 2017-2028
2.2 Global Levofloxacin Revenue Estimates and Forecasts 2017-2028
2.3 Global Levofloxacin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Levofloxacin Sales by Region
2.4.1 Global Levofloxacin Sales by Region (2017-2022)
2.4.2 Global Sales Levofloxacin by Region (2023-2028)
2.5 Global Levofloxacin Revenue by Region
2.5.1 Global Levofloxacin Revenue by Region (2017-2022)
2.5.2 Global Levofloxacin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Levofloxacin Sales by Manufacturers
3.1.1 Global Top Levofloxacin Manufacturers by Sales (2017-2022)
3.1.2 Global Levofloxacin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Levofloxacin in 2021
3.2 Global Levofloxacin Revenue by Manufacturers
3.2.1 Global Levofloxacin Revenue by Manufacturers (2017-2022)
3.2.2 Global Levofloxacin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Levofloxacin Revenue in 2021
3.3 Global Levofloxacin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Levofloxacin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Levofloxacin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Levofloxacin Sales by Type
4.1.1 Global Levofloxacin Historical Sales by Type (2017-2022)
4.1.2 Global Levofloxacin Forecasted Sales by Type (2023-2028)
4.1.3 Global Levofloxacin Sales Market Share by Type (2017-2028)
4.2 Global Levofloxacin Revenue by Type
4.2.1 Global Levofloxacin Historical Revenue by Type (2017-2022)
4.2.2 Global Levofloxacin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Levofloxacin Revenue Market Share by Type (2017-2028)
4.3 Global Levofloxacin Price by Type
4.3.1 Global Levofloxacin Price by Type (2017-2022)
4.3.2 Global Levofloxacin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Levofloxacin Sales by Application
5.1.1 Global Levofloxacin Historical Sales by Application (2017-2022)
5.1.2 Global Levofloxacin Forecasted Sales by Application (2023-2028)
5.1.3 Global Levofloxacin Sales Market Share by Application (2017-2028)
5.2 Global Levofloxacin Revenue by Application
5.2.1 Global Levofloxacin Historical Revenue by Application (2017-2022)
5.2.2 Global Levofloxacin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Levofloxacin Revenue Market Share by Application (2017-2028)
5.3 Global Levofloxacin Price by Application
5.3.1 Global Levofloxacin Price by Application (2017-2022)
5.3.2 Global Levofloxacin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Levofloxacin Market Size by Type
6.1.1 North America Levofloxacin Sales by Type (2017-2028)
6.1.2 North America Levofloxacin Revenue by Type (2017-2028)
6.2 North America Levofloxacin Market Size by Application
6.2.1 North America Levofloxacin Sales by Application (2017-2028)
6.2.2 North America Levofloxacin Revenue by Application (2017-2028)
6.3 North America Levofloxacin Market Size by Country
6.3.1 North America Levofloxacin Sales by Country (2017-2028)
6.3.2 North America Levofloxacin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Levofloxacin Market Size by Type
7.1.1 Europe Levofloxacin Sales by Type (2017-2028)
7.1.2 Europe Levofloxacin Revenue by Type (2017-2028)
7.2 Europe Levofloxacin Market Size by Application
7.2.1 Europe Levofloxacin Sales by Application (2017-2028)
7.2.2 Europe Levofloxacin Revenue by Application (2017-2028)
7.3 Europe Levofloxacin Market Size by Country
7.3.1 Europe Levofloxacin Sales by Country (2017-2028)
7.3.2 Europe Levofloxacin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Levofloxacin Market Size by Type
8.1.1 Asia Pacific Levofloxacin Sales by Type (2017-2028)
8.1.2 Asia Pacific Levofloxacin Revenue by Type (2017-2028)
8.2 Asia Pacific Levofloxacin Market Size by Application
8.2.1 Asia Pacific Levofloxacin Sales by Application (2017-2028)
8.2.2 Asia Pacific Levofloxacin Revenue by Application (2017-2028)
8.3 Asia Pacific Levofloxacin Market Size by Region
8.3.1 Asia Pacific Levofloxacin Sales by Region (2017-2028)
8.3.2 Asia Pacific Levofloxacin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Levofloxacin Market Size by Type
9.1.1 Latin America Levofloxacin Sales by Type (2017-2028)
9.1.2 Latin America Levofloxacin Revenue by Type (2017-2028)
9.2 Latin America Levofloxacin Market Size by Application
9.2.1 Latin America Levofloxacin Sales by Application (2017-2028)
9.2.2 Latin America Levofloxacin Revenue by Application (2017-2028)
9.3 Latin America Levofloxacin Market Size by Country
9.3.1 Latin America Levofloxacin Sales by Country (2017-2028)
9.3.2 Latin America Levofloxacin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Levofloxacin Market Size by Type
10.1.1 Middle East and Africa Levofloxacin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Levofloxacin Revenue by Type (2017-2028)
10.2 Middle East and Africa Levofloxacin Market Size by Application
10.2.1 Middle East and Africa Levofloxacin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Levofloxacin Revenue by Application (2017-2028)
10.3 Middle East and Africa Levofloxacin Market Size by Country
10.3.1 Middle East and Africa Levofloxacin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Levofloxacin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Alna Biotech Private
11.1.1 Alna Biotech Private Corporation Information
11.1.2 Alna Biotech Private Overview
11.1.3 Alna Biotech Private Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Alna Biotech Private Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alna Biotech Private Recent Developments
11.2 Allenge India Pharma
11.2.1 Allenge India Pharma Corporation Information
11.2.2 Allenge India Pharma Overview
11.2.3 Allenge India Pharma Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allenge India Pharma Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allenge India Pharma Recent Developments
11.3 Bestochem
11.3.1 Bestochem Corporation Information
11.3.2 Bestochem Overview
11.3.3 Bestochem Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bestochem Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bestochem Recent Developments
11.4 Divine Savior Healthcare
11.4.1 Divine Savior Healthcare Corporation Information
11.4.2 Divine Savior Healthcare Overview
11.4.3 Divine Savior Healthcare Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Divine Savior Healthcare Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Divine Savior Healthcare Recent Developments
11.5 Glenmark Pharmaceuticals
11.5.1 Glenmark Pharmaceuticals Corporation Information
11.5.2 Glenmark Pharmaceuticals Overview
11.5.3 Glenmark Pharmaceuticals Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Glenmark Pharmaceuticals Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Glenmark Pharmaceuticals Recent Developments
11.6 Pax Healthcare
11.6.1 Pax Healthcare Corporation Information
11.6.2 Pax Healthcare Overview
11.6.3 Pax Healthcare Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pax Healthcare Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pax Healthcare Recent Developments
11.7 Aden Healthcare
11.7.1 Aden Healthcare Corporation Information
11.7.2 Aden Healthcare Overview
11.7.3 Aden Healthcare Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Aden Healthcare Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aden Healthcare Recent Developments
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Corporation Information
11.8.2 Lupin Pharmaceuticals Overview
11.8.3 Lupin Pharmaceuticals Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lupin Pharmaceuticals Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lupin Pharmaceuticals Recent Developments
11.9 Dr. Reddys Laboratories
11.9.1 Dr. Reddys Laboratories Corporation Information
11.9.2 Dr. Reddys Laboratories Overview
11.9.3 Dr. Reddys Laboratories Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Dr. Reddys Laboratories Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dr. Reddys Laboratories Recent Developments
11.10 Zydus Cadila
11.10.1 Zydus Cadila Corporation Information
11.10.2 Zydus Cadila Overview
11.10.3 Zydus Cadila Levofloxacin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zydus Cadila Levofloxacin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zydus Cadila Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Levofloxacin Industry Chain Analysis
12.2 Levofloxacin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Levofloxacin Production Mode & Process
12.4 Levofloxacin Sales and Marketing
12.4.1 Levofloxacin Sales Channels
12.4.2 Levofloxacin Distributors
12.5 Levofloxacin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Levofloxacin Industry Trends
13.2 Levofloxacin Market Drivers
13.3 Levofloxacin Market Challenges
13.4 Levofloxacin Market Restraints
14 Key Findings in The Global Levofloxacin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer